The medical cyclotron is a type of particle accelerator that is used to produce radioisotopes for medical imaging and treatment. The medical cyclotron market has been witnessing steady growth due to the increasing prevalence of cancer and other chronic diseases, which require medical isotopes for diagnosis and treatment. The market is primarily driven by the increasing adoption of nuclear medicine and the rising demand for medical isotopes.
Product segmentation:
The medical cyclotron market is segmented based on product type, application, and end-users. Based on product type, the market is classified into PET cyclotron and SPECT cyclotron. The PET cyclotron segment dominated the market in 2017, and the trend is expected to continue during the forecast period.
Based on application, the market is segmented into oncology, cardiology, neurology, and others. The oncology segment dominated the market in 2017, and the trend is expected to continue during the forecast period.
Based on end-users, the market is segmented into hospitals, diagnostic centers, and research institutions. The hospitals segment dominated the market in 2017, and the trend is expected to continue during the forecast period.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/33117
Regional analysis:
The medical cyclotron market is primarily dominated by North America, Europe, and Asia-Pacific. North America is the largest market for medical cyclotrons due to the increasing prevalence of cancer and other chronic diseases, which require medical isotopes for diagnosis and treatment. Europe is the second-largest market for medical cyclotrons due to the increasing adoption of nuclear medicine and the rising demand for medical isotopes. Asia-Pacific is expected to witness the highest CAGR during the forecast period due to the increasing investment in healthcare infrastructure and the rising demand for medical isotopes.
Key players:
The key players in the medical cyclotron market include IBA Group, Siemens AG, GE Healthcare, Advanced Cyclotron Systems, Inc., Sumitomo Heavy Industries, Ltd., ALCEN, Ebco Industries Ltd., Iotron Industries Canada Inc., Best Cyclotron Systems, and Cyclotron Inc.
Conclusion:
The medical cyclotron market is projected to witness steady growth during the forecast period due to the increasing prevalence of cancer and other chronic diseases, the rising demand for medical isotopes, and the increasing adoption of nuclear medicine. The market is primarily dominated by North America, Europe, and Asia-Pacific, and the key players in the market include IBA Group, Siemens AG, and GE Healthcare.